CDK7 inhibition is a novel therapeutic strategy against GBM both in vitro and in vivo

BACKGROUND: Glioblastoma multiforme (GBM) remains to be one of the top lethal cancer types for adult to date. Current GBM therapies suffer greatly from the highly heterogeneous and adaptable nature of GBM cells, indicating an urgent need of alternative therapeutic options. In this study, we focused...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Manag Res
Hlavní autoři: Meng, Wei, Wang, Jiajia, Wang, Baocheng, Liu, Fang, Li, Meng, Zhao, Yang, Zhang, Chenran, Li, Qifeng, Chen, Juxiang, Zhang, Liye, Tang, Yujie, Ma, Jie
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2018
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6245350/
https://ncbi.nlm.nih.gov/pubmed/30532595
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S183696
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky